ImmuneID’s $50 Million Series A Financing

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised ImmuneID on the deal.ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here